Clinical Trial Update: Parkinson's Disease Biomarker Program

View source ↗

Summary

Clinical trial update describing the completion of the Parkinson's Disease Biomarker Program conducted by the University of Texas Southwestern Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Parkinson's Disease | Status: COMPLETED